Improvement in asymmetric dimethylarginine and oxidative stress in patients with limb salvage after autologous mononuclear stem cell application for critical limb ischemia

BACKGROUND: Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, acts as an inhibitor of angiogenesis and is associated with an increased risk of cardiovascular mortality. Administration of stem cells may affect endogenous mechanisms that regulate ADMA production and...

Descripción completa

Detalles Bibliográficos
Autores principales: Madaric, Juraj, Valachovicova, Martina, Paulis, Ludovit, Pribojova, Jana, Mateova, Renata, Sebekova, Katarina, Postulkova, Luba, Madaricova, Terezia, Bucova, Maria, Mistrik, Martin, Vulev, Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5506609/
https://www.ncbi.nlm.nih.gov/pubmed/28697789
http://dx.doi.org/10.1186/s13287-017-0622-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5506609/
https://www.ncbi.nlm.nih.gov/pubmed/28697789
http://dx.doi.org/10.1186/s13287-017-0622-2

Ejemplares similares